Nifedipine and Kyprolis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nifedipine (nifedipine) and Kyprolis (carfilzomib). Common drug interactions include cardiac failure among females and platelet count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Nifedipine and Kyprolis. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Nifedipine?

Nifedipine has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 53,459 Nifedipine users. Check the latest studies of Nifedipine.

What is Kyprolis?

Kyprolis has active ingredients of carfilzomib. It is often used in multiple myeloma. eHealthMe is studying from 15,080 Kyprolis users. Check the latest studies of Kyprolis.

On Jul, 20, 2026

39 people who take Nifedipine and Kyprolis together, and have interactions are studied.

Nifedipine and Kyprolis drug interactions.

What are the common drug interactions of Nifedipine and Kyprolis, by gender? *:

female:

Cardiac failure
Dementia (madness)
Electrocardiogram t wave inversion
Increased ventricular afterload (increasing left ventricular afterload include elevated blood pressure and aortic valve disease)
Febrile neutropenia (fever with reduced white blood cells)
Bradycardia (abnormally slow heart action)
Chest discomfort
Hyperkalaemia (damage to or disease of the kidney)
Hypotension (abnormally low blood pressure)
Left ventricular failure (left ventricle fails to contract forcefully)

male:

Platelet count decreased
Cardiac failure congestive
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Pleural effusion (water on the lungs)
Rib fracture
Thrombocytopenia (decrease of platelets in blood)
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
C-reactive protein increased
Viral infection
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)

What are the common drug interactions of Nifedipine and Kyprolis, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Anaemia (lack of blood)
Blood calcium increased
Blood creatinine increased
Cardiac arrest
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Pleural effusion (water on the lungs)
Pneumonia
Rib fracture
Thrombocytopenia (decrease of platelets in blood)
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)

60+:

Cardiac failure
Dementia (madness)
Hyperkalaemia (damage to or disease of the kidney)
Hypotension (abnormally low blood pressure)
Left ventricular failure (left ventricle fails to contract forcefully)
Pleural effusion (water on the lungs)
Weight increased
C-reactive protein increased
Viral infection
Acute pulmonary oedema (sudden deposit of fluid in the lung))

What are the existing conditions these people have? *

Oedema (fluid collection in tissue): 2 people, 5.13%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 5.13%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 5.13%
Constipation: 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Nifedipine and Kyprolis?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously